Table 1.
Socio-demographic and baseline clinical characteristics of inulin-initiated T2DM patients at UoGCSH from 2015 to 2020 (N = 405).
Table 2.
The distribution of medications in NPH and premixed insulin-initiated T2DM patients.
Fig 1.
Blood glucose levels during a one-year follow-up period of inulin (NPH vs premixed) initiation.
Table 3.
Comparison of blood glucose levels between NPH and premixed insulin regimens.
Table 4.
The rate of hypoglycemia and glycemic control between NPH and premixed insulin regimens.
Table 5.
Association of NPH and premixed insulin and other predicted variables with hypoglycemia.
Table 6.
Association of NPH and premixed insulin and other predicted variables with glycemic control.